Cumene;methane;1-methyl-3-propan-2-ylindazole;3-propan-2-yl-1,2-benzoxazole;2-propan-2-ylpyridine
C40H56N4O — CID 158832700
Data last refreshed: (MolForge compound catalog, from PubChem)
About Cumene;methane;1-methyl-3-propan-2-ylindazole;3-propan-2-yl-1,2-benzoxazole;2-propan-2-ylpyridine
Cumene;methane;1-methyl-3-propan-2-ylindazole;3-propan-2-yl-1,2-benzoxazole;2-propan-2-ylpyridine (PubChem CID 158832700) has the molecular formula C40H56N4O and a molecular weight of 608.92 g/mol. Its IUPAC name is cumene;methane;1-methyl-3-propan-2-ylindazole;3-propan-2-yl-1,2-benzoxazole;2-propan-2-ylpyridine.
Molecular Properties
| Compound Name | Cumene;methane;1-methyl-3-propan-2-ylindazole;3-propan-2-yl-1,2-benzoxazole;2-propan-2-ylpyridine |
|---|---|
| PubChem CID | 158832700 |
| Molecular Formula | C40H56N4O |
| Molecular Weight | 608.92 g/mol |
| Exact Mass | 608.45 |
| IUPAC Name | cumene;methane;1-methyl-3-propan-2-ylindazole;3-propan-2-yl-1,2-benzoxazole;2-propan-2-ylpyridine |
| SMILES | C.C.CC(C)c1ccccc1.CC(C)c1ccccn1.CC(C)c1nn(C)c2ccccc12.CC(C)c1noc2ccccc12 |
| InChI | InChI=1S/C11H14N2.C10H11NO.C9H12.C8H11N.2CH4/c1-8(2)11-9-6-4-5-7-10(9)13(3)12-11;1-7(2)10-8-5-3-4-6-9(8)12-11-10;1-8(2)9-6-4-3-5-7-9;1-7(2)8-5-3-4-6-9-8;;/h4-8H,1-3H3;3-7H,1-2H3;3-8H,1-2H3;3-7H,1-2H3;2*1H4 |
| InChIKey | IXGBEAJFPGWPIL-UHFFFAOYSA-N |
| XLogP | 11.94 |
| TPSA | 56.74 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 608.92 |
| LogP ≤ 5 | 11.94 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158832700 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.